subject_id=OCCAMS/AH/180;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/194;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/198;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/200;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/204;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/234;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/236;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PL/006;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PL/009;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/037;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/041;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/045;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/046;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/048;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/049;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/050;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/054;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/056;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/046;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/087;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/UC/011;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/UC/014;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/QE/082;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/064;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
